Loomis, Sayles & Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-109
Closed -$4K 919
2023
Q2
$4K Buy
+109
New +$3.33K ﹤0.01% 873
2023
Q1
Sell
-8,422
Closed -$258K 979
2022
Q4
$258K Buy
+8,422
New +$253K ﹤0.01% 494
2022
Q2
Sell
-112
Closed -$4K 984
2022
Q1
$4K Buy
+112
New +$3.5K ﹤0.01% 807
2021
Q3
Sell
-1,045
Closed -$36K 892
2021
Q2
$36K Buy
+1,045
New +$34.6K ﹤0.01% 605
2016
Q2
Sell
-999,315
Closed -$7M 1021
2016
Q1
$7M Sell
999,315
-601,552
-38% -$3.02M 0.02% 458
2015
Q4
$8.58M Sell
1,600,867
-361,242
-18% -$2.31M 0.02% 440
2015
Q3
$12.7M Buy
+1,962,109
New +$20.5M 0.04% 390

Other funds holding CC

Loomis, Sayles & Company's CC Position: Q3 2023 in Review

Loomis, Sayles & Company sold out of Chemours (CC) in Q3 2023, closing a stake of 109 shares — an estimated $4K sold.

Loomis, Sayles & Company first reported a position in CC in Q3 2015 and held it in 7 quarters. The position peaked at $12.7M in Q3 2015. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Loomis, Sayles & Company reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 109 Chemours shares in Q3 2023, an estimated $4K.
  • Loomis, Sayles & Company first reported a position in Chemours in Q3 2015 and held it in 7 quarters.
  • Loomis, Sayles & Company's Chemours position peaked at $12.7M in Q3 2015.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.